Tracked deals
3
3 tracked deals across 2022-2024.
Research Triangle Park, North Carolina, United States
Formerly known as Pro-ficiency (a Simulations Plus company), Pro-ficiency Holdings, Inc., Simulations Plus, Inc.
Immersive, simulation-based training and performance-management platform for clinical trials, including compliance monitoring and analytics. Operates as part of Simulations Plus following the Simulations Plus acquisition of Pro-ficiency.
Tracked deals
3
3 tracked deals across 2022-2024.
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
2 buyout · 1 addon
Last 3 years
Supporting Data
Simulations Plus, Inc. (Nasdaq: SLP) has acquired Pro-ficiency Holdings, Inc. and its subsidiaries from QHP Capital, L.P. and Pro-ficiency's minority shareholders for approximately $100 million in cash. The deal expands Simulations Plus' offerings across the drug development continuum by adding Pro-ficiency's simulation-enabled training, compliance, analytics and medical communications capabilities to its biosimulation platform.
Pro-ficiency has acquired Compass Group Partners and affiliated assets to combine its simulation-based training platform with Compass's life-sciences medical communications capabilities. The deal expands Pro-ficiency's simulation offerings into medical affairs and commercial markets, enabling immersive simulation solutions for pharma and biotech customers and creating new revenue opportunities.
Pro-ficiency has acquired all life-sciences intellectual property and the associated team of Fugitive Labs, bringing Fugitive's product development capabilities and team (led by Erik Guffrey) into Pro-ficiency's platform. The deal expands Pro-ficiency's product development capacity for clinical-trials simulation and performance-management products and is the company's first acquisition since being funded by NovaQuest Private Equity in 2021.
Turn tracked acquisition activity into an outreach-ready buyer list.